Neurotrack

Neurotrack Cognitive Function Test: Assess for MCI, Dementia, Alzheimer

Redwood City, United States · Founded 2012 · $56.6M raised

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$56.6M
Last Round
$10.0M Venture RoundNov 2022
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 9 investors for this company. The full record is or through the API.

About

Neurotrack develops FDA-registered digital cognitive screening tools that help clinicians detect mild cognitive impairment (MCI) and early-stage dementia in as little as 3 minutes. Its platform integrates with all major EHRs, is SOC 2- and HIPAA-compliant, and is used by over 15,000 providers across leading health systems, home health, and primary care settings. Neurotrack's technology is backed by 375+ peer-reviewed publications and funded by the NIA and Gates Foundation.

Summary

Neurotrack is a Digital Health company based in Redwood City, United States, founded in 2012. It has raised $56.6M in total across 8 rounds, most recently a $10.0M Venture Round in Nov 2022. Investors include Founders Fund, Social Capital and Khosla Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundNov 2022
$10.0M

Sign up to see all 8 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
TempusIPO

Tempus is a technology company focused on collecting and analyzing large volumes of molecular and...

Chicago, United States1001–5000Artificial Intelligence, Biotech
Series G+Total funding$960.0MOct 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurotrack on Indexed.vc
<a href="https://indexed.vc/companies/neurotrack"><img src="https://indexed.vc/api/badge/company/neurotrack" alt="Neurotrack on Indexed.vc" width="260" height="76" /></a>